Ref: another poster: I do not expect WP to ‘know’ everything, but I do have a reasonably expectancy that he should know ‘most’ of what needs to be known, you seem to forget that WP made many claims to support our beliefs that everything was well in hand, fact, right up to the end.
It's ok, you can refer to me by name.
The point is that what wasn't known was crucial. You can have a bunch of things going wrong, or one crucial thing going wrong.
In this case that was crucial. The question is was it reasonable?
It is concerning that the team at Admedus totally failed to have a handle on this, the lot of them with all their experience, if that is ‘normal’ why would anybody invest in a spec stock?
Nail on head! The point is it IS speculative and therefore you must look at risk yourself and make your own assessments. It's why there's a disclaimer.
Even with a blue chip stock you can get events that weren't forseen.
Shame not as forgiving on another stock.
The circumstances are entirely different. Both with the company and the discussion mentality. Please stop the oversimplifications. The fact that you pursue me over that, is the clue to why you won't refer to me by name.
If I have lost respect for those who confuse bullying with fair play, I still engage in a reasonable fashion. This should be clear to you and the fact that a majority opinion doesn't make it any more correctly held. This is a very significant point and I'm glad you're seeing it.
AHZ Price at posting:
6.0¢ Sentiment: Buy Disclosure: Held
(20min delay)